国浩律师（南京）事务所 关 于 中国江苏省南京市汉中门大街 309 号 B 座 7-8 层 邮编：210036 7-8/F, Block B, 309 Hanzhongmen Dajie, Nanjing, China, 210036 电话/Tel: +86 25 8966 0900 传真/Fax: +86 2589660966 网址/Website: http://www.grandall.com.cn 二〇二五年五月 国浩律师（南京）事务所 法律意见书 国浩律师（南京）事务所 关于常州瑞华化工工程技术股份有限公司 2024 年年度股东会之 常州瑞华化工工程技术股份有限公司 2024 年年度股东会 之 法律意见书 法律意见书 编号：025202510500994 致：常州瑞华化工工程技术股份有限公司 根据《中华人民共和国公司法》、《北京证券交易所股票上市规则》及其 他法律、法规和规范性文件的要求，国浩律师（南京）事务所（以下称"本 所"）接受常州瑞华化工工程技术股份有限公司（以下称"公司"）的聘请， 指派本所律师出席该公司 2024 年年度股东会，并就公司本次股东会相关事宜出 具法律意见。 为出具本法律意见 ...

证券代码：920099 证券简称：瑞华技术 公告编号：2025-035 常州瑞华化工工程技术股份有限公司 2024 年年度股东会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 2.会议召开地点：公司会议室 3.会议召开方式：现场会议与网络投票相结合 4.会议召集人：董事会 5.会议主持人：徐志刚 6.召开情况合法合规的说明： 本次股东会的召集与召开程序、会议出席人员资格与表决程序均符合《中华 人民共和国公司法》等有关法律法规和《公司章程》的规定，会议合法有效。 （二）会议出席情况 出席和授权出席本次股东会的股东共 19 人，持有表决权的股份总数 38,298,823 股，占公司有表决权股份总数的 48.8505%。 其中通过网络投票参与本次股东会的股东共 2 人，持有表决权的股份总数 111,640 股，占公司有表决权股份总数的 0.1424%。 （一）会议召开情况 1.会议召开时间：2025 年 5 月 27 日 （三）公司董事、监事、高级管理人员出席或列席股东会情况 ...

证券代码：920099 证券简称：瑞华技术 公告编号：2025-034 常州瑞华化工工程技术股份有限公司 股东拟减持股份的预披露公告 本公司及董事会全体成员及相关股东保证公告内容不存在虚假记载、误导性 陈述或重大遗漏，并对其内容的真实、准确和完整承担个别及连带责任。 | 股东名称 | 股东身份 | 持股数量 | 持股比例 | 当前持股 | | --- | --- | --- | --- | --- | | | | （股） | （%） | 股份来源 | | 江苏中小企业发展基金 | 公开承诺股东 | 1,726,097 | 2.2% | 上市前取 | | （有限合伙） | | | | 得 | | 江苏省现代服务业发展创 | 公开承诺股东 | 1,726,062 | 2.2% | 上市前取 | | 业投资基金（有限合伙） | | | | 得 | | 江苏毅达成果创新创业投 | 公开承诺股东 | 1,725,014 | 2.2% | 上市前取 | | 资基金（有限合伙） | | | | 得 | 一、 减持主体的基本情况 江苏中小企业发展基金（有限合伙）、江苏省现代服务业发展创业投资基金 （有限合伙）、江苏毅达成果创 ...

Group 1: Investor Relations Activity Overview - The investor relations activity was an earnings briefing held on May 16, 2025, from 15:00 to 16:30 [3] - The event took place on the "Investor Relations Interactive Platform" [3] - Key attendees included the Chairman, CFO, and other senior executives of the company [3] Group 2: Key Topics Discussed - The earnings briefing included a video interpretation of the annual report and an overview of the company's 2024 operational performance [4] - The catalyst project is expected to commence production in June 2025, with initial revenue and profit gradually increasing [5] - The company is actively monitoring the market for biodegradable plastics due to low demand and will disclose relevant updates [5] Group 3: Market Expansion and Future Projects - The company is expanding its overseas market presence, with ongoing orders from Russia and the Middle East [5] - A new production project in Shandong is planned with a capacity of 200,000 tons/year for PS, SAN, ASA, and MS, which has completed necessary approvals [6] - The company aims to become a globally competitive entity in the petrochemical technology sector through continuous innovation and international exploration [6] Group 4: Profitability and Stock Management - The company is implementing measures to maintain high gross margins on its process packages, including quality improvement and cost optimization [8] - The Chairman has consistently increased his stock holdings, totaling 457,735 shares as of April 30, 2025, indicating confidence in the company's potential [8]

常州瑞华化工工程技术股份有限公司 投资者关系活动记录表 证券代码：920099 证券简称：瑞华技术 公告编号：2025-033 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 情况进行了介绍。同时，公司就投资者在本次说明会中提出的问题进行了回复， 主要问题及回复如下： 问题 1：催化剂项目是否已开始投入生产，从当前情况看，能否达到预期经 营效果？目前催化剂在手订单和客户情况如何？公司两个募投项目今年能够按 时完成吗？ 回答：尊敬的投资者，您好！ 催化剂项目目前已在办理竣工验收相关手续，预计 2025 年 6 月份投产，投 产初期会经历一段时间的产能爬坡，营收和利润会逐步释放。催化剂产品已在市 场销售多年，我们拥有固定客户和在手订单，后续可持续关注公司公告信息。公 司密切关注国家相关政策，目前市场对于可降解塑料需求较为低迷，公司一直在 动态评估可降解项目 ...

2024 年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《北京证券交易所股票上市规则》 等有关法律法规、规范性文件等的规定，中信建投证券股份有限公司（以下简称 "中信建投"或"保荐机构"）作为常州瑞华化工工程技术股份有限公司（以下 简称"瑞华技术"或"公司"）的保荐机构，负责瑞华技术的持续督导工作，并 出具 2024 年度持续督导跟踪报告。 一、持续督导工作概述 中信建投证券股份有限公司 关于常州瑞华化工工程技术股份有限公司 3、督导瑞华技术按照中国证监会、北京证券交易所相关法律法规存放和管 理本次募集资金，定期查询公司募集资金专户，持续关注瑞华技术募集资金使用 情况，以及公司募集资金管理制度执行情况； 4、督导瑞华技术完善规范运作，关注公司三会的运作、表决及披露事项， 督导公司合法合规经营，提升规范运作水平； 5、持续关注瑞华技术及相关股东、董监高的承诺履行情况； 6、2024 年度，针对瑞华技术向全资子公司增资、为全资子公司提供担保、 使用闲置募集资金进行现金管理等事项，共发表了 7 次独立意见； 2024 年度，保荐机构及保荐代表人严格按照《证券发行上市保荐业务管理 办法》《北京证券交易所股 ...

证券代码：920099 证券简称：瑞华技术 公告编号：2025-031 常州瑞华化工工程技术股份有限公司 2024 年年度报告暨 2025 年第一季度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 常州瑞华化工工程技术股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日在北京证券交易所信息披露平台（www.bse.cn）披露了公司《2024 年年度 报告》和《2025 年第一季度报告》。为方便广大投资者更深入了解公司 2024 年 和 2025 年第一季度经营业绩的具体情况，加强与投资者的互动交流，公司拟召 开 2024 年年度报告暨 2025 年第一季度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2025 年 5 月 16 日（星期五）15:00-16:30。 （二）会议召开地点 本次业绩说明会将采用网络远程方式举行，投资者可登录全景网"投资者关 系互动平台"（https://ir.p5w.net）参与。 三、 参加人员 ...

Investment Rating - The report maintains a rating of "Accumulate" for the company [1] Core Views - The company has seen significant growth in equipment revenue, with a projected revenue increase of 40.74% year-on-year for 2024, reaching 555.17 million yuan [2] - The net profit attributable to the parent company for 2024 is expected to grow by 1.78% year-on-year, amounting to 115.95 million yuan [2] - The decline in catalyst revenue is attributed to delivery delays, impacting overall performance [2] Revenue and Profitability Summary - Total revenue for 2024 is projected at 555.17 million yuan, with a year-on-year growth of 40.74% [2] - The net profit for 2024 is estimated at 115.95 million yuan, reflecting a modest growth of 1.78% [2] - The gross profit margin is expected to decrease by 15.44 percentage points to 39.05% in 2024 [2] Revenue Breakdown - Equipment revenue has increased by 171.19% year-on-year to 414 million yuan, accounting for 74.50% of total revenue [2] - Catalyst revenue has decreased by 45.4% year-on-year to 48 million yuan, now representing 8.57% of total revenue [2] - Revenue from process packages and other technical services has dropped by 53.66% to 72 million yuan, making up 12.91% of total revenue [2] Market Position and Future Outlook - The company is recognized as a "small giant" in petrochemical process packages, with leading technology in the domestic market [3] - The establishment of a 12,000-ton catalyst production base is expected to enhance production capacity and meet significant order demand [3] - The company is expanding into biodegradable plastics, which are anticipated to grow rapidly due to regulatory changes in traditional plastics [3] Financial Forecasts - The forecast for net profit attributable to the parent company has been adjusted to 146 million yuan for 2025 and 185 million yuan for 2026 [3] - The projected price-to-earnings ratios for 2025, 2026, and 2027 are 17.49, 13.80, and 10.80 respectively [3]

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The company has seen significant growth in equipment revenue, with a projected revenue increase of 40.74% year-on-year for 2024. The total revenue for 2024 is expected to reach 555.17 million yuan, while the net profit attributable to the parent company is projected to be 115.95 million yuan, reflecting a year-on-year growth of 1.78% [2][3] - The decline in catalyst revenue is attributed to delivery delays, with catalyst-related products experiencing a 45.4% year-on-year decrease in revenue to 48 million yuan, accounting for 8.57% of total revenue [2] - The company is focusing on integrating its supply chain and enhancing cooperation with upstream suppliers and downstream customers, which has contributed to the revenue growth [2] Summary by Sections Financial Performance - Total revenue for 2023 was 394.47 million yuan, with a projected increase to 555.17 million yuan in 2024, representing a 40.74% year-on-year growth. The net profit for 2023 was 113.93 million yuan, expected to rise to 115.95 million yuan in 2024, showing a modest growth of 1.78% [1][2] - The company's sales gross margin decreased by 15.44 percentage points to 39.05%, while the net profit margin fell by 7.99 percentage points to 20.89% [2] Revenue Breakdown - Equipment revenue surged by 171.19% year-on-year to 414 million yuan, making up 74.50% of total revenue, with a gross margin of 28.82% [2] - Revenue from catalyst products dropped significantly due to project delays, while revenue from process packages and other technical services also saw declines [2][3] Market Position and Future Outlook - The company is recognized as a "small giant" in petrochemical process packages, with leading technology in the industry. The projected net profit for 2025 is adjusted to 146 million yuan, with further growth expected in subsequent years [3] - The company is expanding into biodegradable plastics, which are anticipated to grow rapidly due to regulatory changes affecting traditional plastics [3]

上 市 公 司 基础化工 2025 年 04 月 30 日 瑞华技术 (920099) ——部分催化剂延期至 25Q1 交付，大额回款冲回损失 报告原因：有业绩公布需要点评 增持（维持） | 市场数据： | 2025 年 04 月 30 日 | | --- | --- | | 收盘价（元） | 32.55 | | 一年内最高/最低（元） | 44.88/21.10 | | 市净率 | 3.0 | | 股息率%（分红/股价） | 1.54 | | 流通 A 股市值（百万元） | 1,282 | | 上证指数/深证成指 | 3,279.03/9,899.82 | | 注："股息率"以最近一年已公布分红计算 | | | 基础数据: | 2025 年 03 月 31 日 | | --- | --- | | 每股净资产（元） | 10.80 | | 资产负债率% | 39.87 | | 总股本/流通 A 股（百万） | 78/39 | | 流通 B 股/H 股（百万） | -/- | 一年内股价与大盘对比走势： 09-25 10-25 11-25 12-25 01-25 02-25 03-25 04-25 -20% 0 ...